Comparison of therapeutic efficacy of topical PUVA, oral etretinate, and combined PUVA and etretinate for the treatment of psoriasis and development of PUVA lentigines and antinuclear antibodies.
Takashima
A
A
Sunohara
A
A
Matsunami
E
E
Mizuno
N
N
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000096:biosynthesis*; D005050:Etretinate / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007911:Lentigo / Q000139:chemically induced* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011701:PUVA Therapy / Q000009:adverse effects; D011565:Psoriasis / Q000188:drug therapy*
D000974:Antibodies, Antinuclear; D005050:Etretinate